Sugmin GP 2mg/500mg/15mg Tablet SR
Marketer
Pink Health
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Sugmin GP 2mg/500mg/15mg Tablet SR
Diabetic patients using Glymin-D 2mg/500mg/15mg sustained-release tablets can experience improved blood glucose management. This triple-action formulation, used alongside diet and exercise, enhances insulin effectiveness in adults with type 2 diabetes. Dosage and frequency should strictly follow your physician's instructions; always take with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless the next dose is imminent; avoid doubling the dose. Excessive intake may result in hypoglycemia. Concurrent use with other diabetes medications, alcohol consumption, or meal skipping raises hypoglycemia risk; regular blood glucose monitoring is crucial. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and upper respiratory infections. Prior to commencing treatment, inform your doctor of any existing kidney, liver, or heart conditions; pregnancy or breastfeeding requires consultation. Baseline kidney function tests are mandatory before initiating therapy. Limit alcohol consumption to mitigate potential side effects.
Uses of Sugmin GP 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Sugmin GP 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Sugmin GP 2mg/500mg/15mg Extended-Release Tablets with food.
Common Side effects of Sugmin GP 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Sugmin GP 2mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Sugmin GP 2mg/500mg/15mg Tablet SR. Ingest the tablet whole; do not crush, chew, or fracture it. This medication should be administered with food.
How Sugmin GP 2mg/500mg/15mg Tablet SR works:
Sugmin GP 2mg/500mg/15mg Extended-Release Tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to enhance blood glucose management when monotherapy or dual therapy proves inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin sensitivity. Pioglitazone, a thiazolidinedione, further enhances insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Sugmin GP 2mg/500mg/15mg SR tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Sugmin GP 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Sugmin GP 2mg/500mg/15mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use the extended-release Sugmin GP 2mg/500mg/15mg tablet cautiously, potentially requiring dosage modification. Consult your physician. The medication is contraindicated for individuals with severe kidney disease. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Sugmin GP 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Sugmin GP 2mg/500mg/15mg SR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Sugmin GP 2mg/500mg/15mg Tablet SR :
Should you forget a dose of Sugmin GP 2mg/500mg/15mg Tablet SR, ingest it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Sugmin GP 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently